First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a slight upward shift in utilization per claim and cost per claim. Even with these changes, opioids remain the #1 therapeutic class by usage and cost, however, 2019 marked the largest reduction of the last 5 years in the percentage of opioid scripts with greater than or equal to 90 MED. View the video blog here.
As the telemedicine industry continues to boom we’re seeing more and more new forms of telehealth emerge in the marketplace.
Lyrica (pregabalin) is one of the most commonly prescribed drugs for neuropathic pain.
SAN DIEGO, CA—Mitchell, a leading provider of technology, connectivity and information solutions to the
Keep current with new legislation and its potential effect on your organization.
In 2018, First Script realized a 0.6% increase in generic utilization.
Keep current with new legislation and its potential effect on your organization.